Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Dilber

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Advances in Experimental Medicine and Biology|February 23, 1999
Gene marking and gene therapy in multiple myelomaG Gahrton, B Björkstrand, M S Dilber, et al.
Human Gene Therapy|October 1, 1994
Retroviral-mediated gene transfer of CD34-enriched bone marrow and peripheral blood cells during autologous stem cell transplantation for multiple myelomaB Björkstrand, G Gahrton, M S Dilber, et al.
British Journal of Haematology|November 20, 2008
The prognostic significance of 8p21 deletion in multiple myelomaT Sutlu, E Alici, M Jansson, et al.
Experimental Hematology|November 1, 1994
Basic fibroblast growth factor increases retroviral-mediated gene transfer into human hematopoietic peripheral blood progenitor cellsM S Dilber, B Björkstrand, K J Li, et al.
Cytokine|June 9, 2001
Expression and release of stable and active forms of murine granulocyte-macrophage colony-stimulating factor (mGM-CSF) targeted to different subcellular compartmentsH J Arteaga, A J Mohamed, B Christensson, et al.
Cancer Gene Therapy|November 4, 2006
Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myelomaE Alici, B Björkstrand, A Treschow, et al.
Leukemia|September 27, 2003
Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapyH Guven, M Gilljam, B J Chambers, et al.
Leukemia|March 3, 2006
Evaluation of ex vivo expanded human NK cells on antileukemia activity in SCID-beige miceF Guimarães, H Guven, D Donati, et al.
Gene Therapy|May 26, 1999
Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22M S Dilber, A Phelan, A Aints, et al.
Blood|September 15, 1996
Suicide gene therapy for plasma cell tumorsM S Dilber, M R Abedi, B Björkstrand, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Advances in Experimental Medicine and Biology|February 23, 1999
Gene marking and gene therapy in multiple myelomaG Gahrton, B Björkstrand, M S Dilber, et al.
Human Gene Therapy|October 1, 1994
Retroviral-mediated gene transfer of CD34-enriched bone marrow and peripheral blood cells during autologous stem cell transplantation for multiple myelomaB Björkstrand, G Gahrton, M S Dilber, et al.
British Journal of Haematology|November 20, 2008
The prognostic significance of 8p21 deletion in multiple myelomaT Sutlu, E Alici, M Jansson, et al.
Experimental Hematology|November 1, 1994
Basic fibroblast growth factor increases retroviral-mediated gene transfer into human hematopoietic peripheral blood progenitor cellsM S Dilber, B Björkstrand, K J Li, et al.
Cytokine|June 9, 2001
Expression and release of stable and active forms of murine granulocyte-macrophage colony-stimulating factor (mGM-CSF) targeted to different subcellular compartmentsH J Arteaga, A J Mohamed, B Christensson, et al.
Cancer Gene Therapy|November 4, 2006
Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myelomaE Alici, B Björkstrand, A Treschow, et al.
Leukemia|September 27, 2003
Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapyH Guven, M Gilljam, B J Chambers, et al.
Leukemia|March 3, 2006
Evaluation of ex vivo expanded human NK cells on antileukemia activity in SCID-beige miceF Guimarães, H Guven, D Donati, et al.
Gene Therapy|May 26, 1999
Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22M S Dilber, A Phelan, A Aints, et al.
Blood|September 15, 1996
Suicide gene therapy for plasma cell tumorsM S Dilber, M R Abedi, B Björkstrand, et al.
Pageof 3